KATIE HODGES: Open Payments
NPI 1669155347 · BENSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 27 payments from 15 companies in 2025. Trend: 2023 $43 · 2024 $658 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $117 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Corcept Therapeutics | 2 | $50 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Indivior Inc. | 1 | $32 |
| SHIELD THERAPEUTICS INC | 2 | $31 |
| Lundbeck LLC | 1 | $20 |
Products named: CAPLYTA, REXULTI, Korlym, INGREZZA, JARDIANCE, FARXIGA, SUBLOCADE, ACCRUFER.
Industry payments across NC — which companies pay providers there.
